JG
NVAX icon

Jain Global’s Novavax NVAX Stock Holding History

Jain Global’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,838
Closed -$88.7K – 1495
2025
Q1 		$88.7K Buy
+13,838
New +$114K ﹤0.01% 974

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jain Global's NVAX Position: Q2 2025 in Review

Jain Global sold out of Novavax (NVAX) in Q2 2025, closing a stake of 13,838 shares — an estimated $88.7K sold.

Jain Global first reported a position in NVAX in Q1 2025 and held it in 1 quarter. The position peaked at $88.7K in Q1 2025. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Jain Global reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Jain Global sold 13,838 Novavax shares in Q2 2025, an estimated $88.7K.
  • Jain Global first reported a position in Novavax in Q1 2025 and held it in 1 quarter.
  • Jain Global's Novavax position peaked at $88.7K in Q1 2025.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.